miR-152-mediated MKK7 downregulation is attenuated by MYCNOS in ovarian adenocarcinoma

Guifang Zhang1, Dan Zheng1, Xiaoqing Chen2

  • 1Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330008, P.R. China.

Oncology Letters
|November 4, 2021
PubMed

Insights

MYCN opposite strand (MYCNOS) is upregulated in ovarian adenocarcinoma, promoting cancer cell proliferation by sponging miR-152 and upregulating MKK7. This oncogenic lncRNA indicates poor prognosis in OA patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The oncogenic role of MYCN opposite strand (MYCNOS) long non-coding RNA is established in liver cancer.
  • Its function in ovarian adenocarcinoma (OA) remains largely unexplored.

Purpose of the Study:

  • To investigate the role and mechanism of MYCNOS in ovarian adenocarcinoma.
  • To determine the prognostic value of MYCNOS in OA.

Main Methods:

  • MYCNOS expression analyzed via RT-qPCR.
  • Prognostic value assessed in a 5-year follow-up.
  • MYCNOS-miR-152 interaction confirmed using dual luciferase reporter assay.
  • Effects on MKK7 expression and cell proliferation evaluated.

Main Results:

  • MYCNOS expression is significantly upregulated in OA tissues.
  • High MYCNOS expression correlates with poor patient survival.
  • MYCNOS sponges miR-152, leading to MKK7 upregulation and increased cell proliferation.
  • MYCNOS overexpression counteracts miR-152's inhibitory effects.

Conclusions:

  • MYCNOS functions as an oncogenic lncRNA in ovarian adenocarcinoma.
  • MYCNOS promotes OA cell proliferation by inhibiting miR-152 and upregulating MKK7.
  • MYCNOS serves as a potential prognostic biomarker for OA.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K